Not applicableEnded earlyNCT03994224
What this trial is testing
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD
Who this might be right for
Crohn DiseasePerianal Crohn Disease
Chinese University of Hong Kong 13